Mechanisms of bone resorption in periodontitis

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Hienz, Stefan A ^a   Paliwal, Sweta ^a   Ivanovski, Saso ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 17; INTERLEUKIN 6; KININ; LYMPHOTOXIN; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; THROMBIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL LOAD; BONE CELL; BONE CHARACTERISTICS AND FUNCTIONS; BONE MINERALIZATION; BONE REMODELING; CELL FUNCTION; DEGRADATION; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MEDIATOR RELEASE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTITIS; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ALVEOLAR BONE LOSS; ANIMAL; IMMUNOLOGY; INFLAMMATION;

ALVEOLAR BONE LOSS; ANIMALS; BONE RESORPTION; HUMANS; INFLAMMATION; OSTEOCLASTS; PERIODONTITIS; RANK LIGAND;

EID: 84930006794     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/615486     Document Type: Article

References (81)

1. A. Di Benedetto, I. Gigante, S. Colucci, and M. Grano, "Periodontal disease: linking the primary inflammation to bone loss, " Clinical and Developmental Immunology, vol. 2013, Article ID 503754, 7 pages, 2013.
2. A. Nanci and D. D. Bosshardt, "Structure of periodontal tissues in health and disease, " Periodontology 2000, vol. 40, no. 1, pp. 11-28, 2006.
3. T. W. Oates and D. L. Cochran, "Bone cell interactions and regulation by inflammatory mediators, " Current Opinion in Periodontology, vol. 3, pp. 34-44, 1996.
4. Z. Schwartz, J.Goultschin, D.D.Dean, and B.D. Boyan, "Mechanisms of alveolar bone destruction in periodontitis, " Periodontology 2000, vol. 14, no. 1, pp. 158-172, 1997.
5. R. Gruber, Molecular and Cellular Basis of Bone Resorption, Wiener MedizinischeWochenschrift, 2014.
6. L. K. McCauley and R.M.Nohutcu, "Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy, " Journal of Periodontology, vol. 73, no. 11, pp. 1377-1391, 2002.
7. M. G. Newman, H. Takei, P. R. Klokkevold, and F. A. Carranza, Carranza's Clinical Periodontology, Elsevier Saunders, St. Louis, Mo, USA, 11th edition, 2012.
8. R. Baron, "Molecular mechanisms of bone resorption. An update, " Acta Orthopaedica Scandinavica, Supplement, vol. 66, no. 266, pp. 66-70, 1995.
9. R. Baron, "Molecular mechanisms of bone resorption by the osteoclast, " Anatomical Record, vol. 224, no. 2, pp. 317-324, 1989.
10. R. Baron, "Molecular mechanisms of bone resorption. An update, " Acta Orthopaedica Scandinavica, Supplement, vol. 66, no. 266, pp. 66-70, 1995.
11. M. A. Taubman, P. Valverde, X. Han, and T. Kawai, "Immune response: the key to bone resorption in periodontal disease, " Journal of Periodontology, vol. 76, no. 11, supplement, pp. 2033-2041, 2005.
12. A. Bruzzaniti and R. Baron, "Molecular regulation of osteoclast activity, " Reviews in Endocrine and Metabolic Disorders, vol. 7, no. 1-2, pp. 123-139, 2006.
13. S. L. Teitelbaum, "Bone resorption by osteoclasts, " Science, vol. 289, no. 5484, pp. 1504-1508, 2000.
14. S. L. Teitelbaum, "Osteoclasts: what do they do and how do they do it?" The American Journal of Pathology, vol. 170, no. 2, pp. 427-435, 2007.
15. P. Gehron Robey, "The biochemistry of bone, " Endocrinology andMetabolismClinics ofNorthAmerica, vol. 18, no. 4, pp. 858-902, 1989.
16. C. Raynal, P. D. Delmas, and C. Chenu, "Bone sialoprotein stimulates in vitro bone resorption, " Endocrinology, vol. 137, no. 6, pp. 2347-2354, 1996.
17. H. I. Roach, "Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption, " Cell Biology International, vol. 18, no. 6, pp.617-628, 1994.
18. W.V.Giannobile, K. F.Al-Shammari, andD.P.Sarment, "Matrix molecules and growth factors as indicators of periodontal disease activity, " Periodontology 2000, vol. 31, pp. 125-134, 2003.
19. P. R. Garant, Oral Cells and Tissues, Quintessence Publishing Co., 2003.
20. Z. Bar-Shavit, "Theosteoclast: amultinucleated, hematopoieticorigin, bone-resorbing osteoimmune cell, " Journal of Cellular Biochemistry, vol. 102, no. 5, pp. 1130-1139, 2007.
21. J. M. W. Quinn, S. Neale, Y. Fujikawa, J. D. McGee, and N. A. Athanasou, "Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells, " Calcified Tissue International, vol. 62, no. 6, pp. 527-531, 1998.
22. H. Yasuda, N. Shima, N. Nakagawa et al., "Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3597-3602, 1998.
23. J.-L. Saffar, J.-J. Lasfargues, and M. Cherruau, "Alveolar bone and the alveolar process: the socket that is never stable, " Periodontology 2000, vol. 14, no. 1, pp. 76-90, 1997.
24. D. Liu, J. K. Xu, L. Figliomeni et al., "Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction, " International Journal of Molecular Medicine, vol. 11, no. 1, pp. 17-21, 2003.
25. T. Nagasawa, M. Kiji, R. Yashiro et al., "Roles of receptor activator of nuclear factor-B ligand (RANKL) and osteoprotegerin in periodontal health and disease, " Periodontology 2000, vol. 43, no. 1, pp. 65-84, 2007.
26. S. Tanaka, N. Takahashi, N. Udagawa et al., "Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors, " Journal of Clinical Investigation, vol. 91, no. 1, pp. 257-263, 1993.
27. N. Udagawa, N. Takahashi, E. Jimi et al., "Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand, " Bone, vol. 25, no. 5, pp. 517-523, 1999.
28. W. Zou and Z. Bar-Shavit, "Dual modulation of osteoclast differentiation by lipopolysaccharide, " Journal of Bone and Mineral Research, vol. 17, no. 7, pp. 1211-1218, 2002.
29. S. Bord, A. Horner, R. M. Hembry, J. J. Reynolds, and J. E. Compston, "Production of collagenase by human osteoblasts and osteoclasts in vivo, " Bone, vol. 19, no. 1, pp. 35-40, 1996.
30. N. Udagawa, N. Sato, S. Yang et al., "Signal transduction of lipopolysaccharide-induced osteoclast differentiation, " Periodontology 2000, vol. 43, no. 1, pp. 56-64, 2007.
31. P. T. Lakkakorpi and H. K. Vaänänen, "Cytoskeletal changes in osteoclasts during the resorption cycle, " Microscopy Research and Technique, vol. 33, no. 2, pp. 171-181, 1996.
32. A. M. Parfitt, "The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis, " Metabolic Bone Disease and Related Research, vol. 4, no. 1, pp. 1-6, 1982.
33. M. Zaidi, A. S. Alam, V. S. Shankar et al., "Cellular biology of bone resorption, " Biological Reviews of the Cambridge Philosophical Society, vol. 68, no. 2, pp. 197-264, 1993.
34. M. Zaidi, H. C. Blair, B. S. Moonga, E. Abe, and C. L.-H. Huang, "Osteoclastogenesis, bone resorption, and osteoclastbased therapeutics, " Journal of Bone and Mineral Research, vol. 18, no. 4, pp. 599-609, 2003.
35. T. J. Chambers, "The pathobiology of the osteoclast, " Journal of Clinical Pathology, vol. 38, no. 3, pp. 241-252, 1985.
36. B. R. MacDonald, "Parathyroid hormone, prostaglandins and bone resorption, "World Review of Nutrition and Dietetics, vol. 47, pp. 163-201, 1986.
37. R. Gruber, "Cell biology of osteoimmunology, " Wiener MedizinischeWochenschrift, vol. 160, no. 17-18, pp. 438-445, 2010.
38. H. Kaji, T. Sugimoto, M. Kanatani et al., "Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity, " Endocrinology, vol. 134, no. 4, pp. 1897-1904, 1994.
39. J. L. Ebersole, "Humoral immune responses in gingival crevice fluid: local and systemic implications, " Periodontology 2000, vol. 31, pp. 135-166, 2003.
40. J. L. Ebersole, D. R. Dawson, L. A. Morford, R. Peyyala, C. S. Miller, and O. A. Gonzaléz, "Periodontal disease immunology: "double indemnity" in protecting the host, " Periodontology 2000, vol. 62, no. 1, pp. 163-202, 2013.
41. W. V. Giannobile, "Crevicular fluid biomarkers of oral bone loss, " Current Opinion in Periodontology, vol. 4, pp. 11-20, 1997.
42. G. Gupta, "Gingival crevicular fluid as a periodontal diagnostic indicator-II: inflammatory mediators, host-response modifiers and chair side diagnostic aids, " Journal ofMedicine and Life, vol. 6, no. 1, pp. 7-13, 2013.
43. A. Holmlund, L. Hänström, and U. H. Lerner, "Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease, " Journal of Clinical Periodontology, vol. 31, no. 6, pp. 475-482, 2004.
44. M. Gowen and G. R. Mundy, "Actions of recombinant interleukin 1, interleukin 2, and interferon- on bone resorption in vitro, " Journal of Immunology, vol. 136, no. 7, pp. 2478-2482, 1986.
45. I. B. Lamster and M. J. Novak, "Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease, " Critical Reviews in Oral Biology & Medicine, vol. 3, no. 1-2, pp. 31-60, 1992.
46. L.C.Hofbauer, S.Khosla, C. R.Dunstan, D. L. Lacey, W. J.Boyle, and B. L. Riggs, "The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption, " Journal of Bone and Mineral Research, vol. 15, no. 1, pp. 2-12, 2000.
47. Q. Jin, J. A. Cirelli, C. H. Park et al., "RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis, " Journal of Periodontology, vol. 78, no. 7, pp. 1300-1308, 2007.
48. T. Kawai, T. Matsuyama, Y. Hosokawa et al., "B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease, " The American Journal of Pathology, vol. 169, no. 3, pp. 987-998, 2006.
49. X. Han, T. Kawai, and M. A. Taubman, "Interference with immune-cell-mediated bone resorption in periodontal disease, " Periodontology 2000, vol. 45, no. 1, pp. 76-94, 2007.
50. E. J. Ohlrich, M. P. Cullinan, and G. J. Seymour, "The immunopathogenesis of periodontal disease, " Australian Dental Journal, vol. 54, supplement 1, pp. S2-S10, 2009.
51. T. Yucel-Lindberg and T. Bage, "Inflammatory mediators in the pathogenesis of periodontitis, " Expert Reviews in Molecular Medicine, vol. 15, p. e7, 2013.
52. G.N. Belibasakis andN. Bostanci, "TheRANKL-OPGsystemin clinical periodontology, " Journal of Clinical Periodontology, vol. 39, no. 3, pp. 239-248, 2012.
53. M. A. Taubman and T. Kawai, "Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption, " Critical Reviews in Oral Biology andMedicine, vol. 12, no. 2, pp. 125-135, 2001.
54. E. AlShwaimi, E. Berggreen, H. Furusho et al., "IL-17 receptor a signaling is protective in infection-stimulated periapical bone destruction, " Journal of Immunology, vol. 191, no. 4, pp. 1785-1791, 2013.
55. S. L. Gaffen and G. Hajishengallis, "A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigmin the context ofTh17 cells and IL-17, " Journal of Dental Research, vol. 87, no. 9, pp. 817-828, 2008.
56. P. D. Marsh, "Microbial ecology of dental plaque and its significance in health and disease, " Advances in Dental Research, vol. 8, no. 2, pp. 263-271, 1994.
57. R. P.Darveau, "Periodontitis: a polymicrobial disruption of host homeostasis, "Nature ReviewsMicrobiology, vol. 8, no. 7, pp. 481-490, 2010.
58. S. S. Socransky, A.D.Haffajee, M. A. Cugini, C. Smith, and R. L. Kent Jr., "Microbial complexes in subgingival plaque, " Journal of Clinical Periodontology, vol. 25, no. 2, pp. 134-144, 1998.
59. S. C. Holt and J. L. Ebersole, "Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis, " Periodontology 2000, vol. 38, no. 1, pp. 72-122, 2005.
60. G.Hajishengallis, S. Liang, M. A. Payne et al., "Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement, " CellHost and Microbe, vol. 10, no. 5, pp. 497-506, 2011.
61. G. Hajishengallis, "Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response, " Trends in Immunology, vol. 35, no. 1, pp. 3-11, 2014.
62. G. Hajishengallis, R. P. Darveau, and M. A. Curtis, "The keystone-pathogen hypothesis, " Nature Reviews Microbiology, vol. 10, no. 10, pp. 717-725, 2012.
63. G. Hajishengallis and S. E. Sahingur, "Novel inflammatory pathways in periodontitis, " Advances in Dental Research, vol. 26, no. 1, pp. 23-29, 2014.
64. R. Claesson, A. Johansson, G. Belibasakis, L. Hänström, and S. Kalfas, "Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans, " Journal of Periodontal Research, vol. 37, no. 5, pp. 353-359, 2002.
65. J. S. Kinney, T.Morelli, M. Oh et al., "Crevicular fluid biomarkers and periodontal disease progression, " Journal of Clinical Periodontology, vol. 41, no. 2, pp. 113-120, 2014.
66. S.Grosskinsky, M. Schott, C. Brenner, S. J. Cutler, M.M. Simon, and R. Wallich, "Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis, " PLoS Neglected Tropical Diseases, vol. 4, no. 6, article no. e698, 2010.
67. T. Meri, H. Amdahl, M. J. Lehtinen et al., "Microbes bind complement inhibitor factor H via a common site, " PLoS Pathogens, vol. 9, no. 4, Article ID e1003308, 2013.
68. D. P.Miller, J. V. Mcdowell, J. K. Bell, M. P. Goetting-Minesky, J. C. Fenno, and R. T. Marconi, "Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease, "MolecularOralMicrobiology, vol. 29, no. 5, pp. 194-207, 2014.
69. F. Spyrakis, B. Cellini, S. Bruno et al., "Targeting Cystalysin, a virulence factor of treponema denticola-supported periodontitis, " ChemMedChem, vol. 9, no. 7, pp. 1501-1511, 2014.
70. R. P. Settem, K. Honma, and A. Sharma, "Neutrophil mobilization by surface-glycan altered Th17-skewing bacteria mitigates periodontal pathogen persistence and associated alveolar bone loss, " PLoS ONE, vol. 9, no. 9, Article ID e108030, 2014.
71. G. Posch, G. Sekot, V. Friedrich et al., "Glycobiology aspects of the periodontal pathogen Tannerella forsythia, " Biomolecules, vol. 2, no. 4, pp. 467-482, 2012.
72. G. Sekot, G. Posch, P.Messner et al., "Potential of the Tannerella forsythia S-layer to delay the immune response, " Journal of Dental Research, vol. 90, no. 1, pp. 109-114, 2011.
73. R. P. Settem, K. Honma, T. Nakajima et al., "A bacterial glycan core linked to surface (S)-layer proteins modulates host immunity throughTh17 suppression, "Mucosal Immunology, vol. 6, no. 2, pp. 415-426, 2013.
74. D. M. Underhill and A. Ozinsky, "Toll-like receptors: keymediators of microbe detection, " Current Opinion in Immunology, vol. 14, no. 1, pp. 103-110, 2002.
75. P. Mark Bartold and T. E. van Dyke, "Periodontitis: a hostmediated disruption of microbial homeostasis. Unlearning learned concepts, " Periodontology 2000, vol. 62, no. 1, pp. 203-217, 2013.
76. A. L. Dumitrescu, S. A. El-Aleem, B. Morales-Aza, and L. F. Donaldson, "A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation, " Journal of Clinical Periodontology, vol. 31, no. 8, pp. 596-603, 2004.
77. T. D. K. Herath, R. P. Darveau, C. J. Seneviratne, C.-Y.Wang, Y. Wang, and L. Jin, "Tetra-and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-kappaB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts, " PLoS ONE, vol. 8, no. 3, Article ID e58496, 2013.
78. S. Jain, S. R. Coats, A. M. Chang, and R. P. Darveau, "A novel class of lipoprotein lipase-sensitive moleculesmediates toll-like receptor 2 activation by Porphyromonas gingivalis, " Infection and Immunity, vol. 81, no. 4, pp. 1277-1286, 2013.
79. C. Slocum, S. R. Coats, N. Hua et al., "Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation, " PLoS Pathogens, vol. 10, no. 7, Article IDe1004215, 2014.
80. G. Hajishengallis and J. D. Lambris, "Complement-targeted therapeutics in periodontitis, " Advances in Experimental Medicine and Biology, vol. 735, pp. 197-206, 2013.
81. G. Hajishengallis and R. J. Lamont, "Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology, " Molecular Oral Microbiology, vol. 27, no. 6, pp. 409-419, 2012.